SER SERINA THERAPEUTICS INC Management Changes 8-K Filing 2023 - Termination of Agreement AgeX Therapeutics terminates agreement with Juvenescence Limited, resulting in the departure of Chief Operating Officer Nafees Malik.Get access to all SEC 8-K filings of the SERINA THERAPEUTICS INC